Macrophage migration inhibitory factor in myocardial ischaemia/reperfusion injury

Cardiovascular Research

Volumn 102, Issue 2, 2014, Pages 321-328

  Rassaf, Tienush ^a   Weber, Christian ^b   Bernhagen, Jürgen ^c  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Cardioprotection; Macrophage migration inhibitory factor; Myocardial ischaemia reperfusion injury

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MACROPHAGE MIGRATION INHIBITION FACTOR;

ACUTE HEART INFARCTION; APOPTOSIS; ATHEROGENESIS; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CLINICAL STUDY; GLUCOSE METABOLISM; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART PROTECTION; HEART VENTRICLE REMODELING; HUMAN; METABOLIC REGULATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REDOX STRESS; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; METABOLISM; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; HUMANS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; OXIDATION-REDUCTION; SIGNAL TRANSDUCTION;

EID: 84899065409     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvu071     Document Type: Review

References (64)

1. Lopez AD Mathers CD Ezzati M Jamison DT Murray CJ. Global and regional burden of disease and risk factors 2001: Systematic analysis of population health data. Lancet 2006; 367:1747-1757
2. Yellon DM Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 2007;357: 1121-1135
3. Zernecke A Bernhagen JWeber C. Macrophage migration inhibitory factor in cardiovascular disease. Circulation 2008;117:1594-1602
4. David JR. Delayed hypersensitivity in vitro: Its mediation by cell-free substances formed by lymphoid cell-Antigen interaction. Proc Natl Acad Sci USA 1966;56:72-77
5. CalandraT Bernhagen J MetzCNSpiegel LA Bacher M DonnellyT Cerami A Bucala R. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995;377: 68-71
6. Bernhagen J Calandra T Mitchell RA Martin SB Tracey KJ Voelter W Manogue KR Cerami A Bucala R. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 1993;365:756-759
7. Nguyen MT Lue H Kleemann R Thiele M Tolle G Finkelmeier DWagner E Braun A Bernhagen J. The cytokine macrophage migration inhibitory factor reduces pro-oxidative stress-induced apoptosis. J Immunol 2003;170:3337-3347
8. Calandra T Roger T. Macrophage migration inhibitory factor: A regulator of innate immunity. Nat Rev Immunol 2003;3:791-800
9. Bernhagen J Krohn R Lue H Gregory JL Zernecke A Koenen RR Dewor M Georgiev I Schober A Leng L Kooistra T Fingerle-Rowson G Ghezzi P Kleemann R McColl SR Bucala R Hickey MJWeber C. MIF is a noncognate ligand ofCXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 2007;13:587-596
10. Luedike P Hendgen-Cotta UB Sobierajski J Totzeck M Reeh M Dewor M Lue H Krisp C Wolters D Kelm M Bernhagen J Rassaf T. Cardioprotection through S-nitros(yl)ation of macrophage migration inhibitory factor. Circulation 2012;125: 1880-1889
11. Takahashi M Nishihira J Shimpo M Mizue Y Ueno S Mano H Kobayashi E Ikeda U Shimada K. Macrophage migration inhibitory factor as a redox-sensitive cytokine in cardiac myocytes. Cardiovasc Res 2001;52:438-445
12. Hattori T Shimokawa H Higashi M Hiroki J Mukai Y Tsutsui H Kaibuchi K Takeshita A. Long-Term inhibition of Rho-kinase suppresses left ventricular remodeling after myocardial infarction in mice. Circulation 2004;109:2234-2239
13. Miller EJ Li J Leng L McDonald C Atsumi T Bucala R Young LH. Macrophage migration inhibitory factor stimulates AMP-Activated protein kinase in the ischaemic heart. Nature 2008;451:578-582
14. Qi D Hu XWuX Merk M Leng L Bucala R Young LH. Cardiac macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia/reperfusion. J Clin Invest 2009;119:3807-3816
15. Ma HWang J Thomas DP Tong C Leng LWangW Merk M Zierow S Bernhagen J Ren J Bucala R Li J. Impaired macrophage migration inhibitory factor-AMP-Activated protein kinase activation and ischemic recovery in the senescent heart. Circulation 2010;122:282-292
16. Koga K Kenessey A Powell SR Sison CP Miller EJ Ojamaa K. Macrophage migration inhibitory factor provides cardioprotection During ischemia/reperfusion by reducing oxidative stress. Antioxid Redox Signal 2011;14:1191-1202
17. GaoXMLiuY White D SuY DrewBG Bruce CR Kiriazis HXuQ Jennings N Bobik A Febbraio MA Kingwell BA Bucala R Fingerle-Rowson G Dart AM Morand EF Du XJ. Deletion of macrophage migration inhibitory factor protects the heart from severe ischemia-reperfusion injury: A predominant role of anti-inflammation. J Mol Cell Cardiol 2011;50:991-999
18. Wang J Tong C Yan X Yeung E Gandavadi S Hare AA Du X Chen Y Xiong H Ma C Leng L Young LH Jorgensen WL Li J Bucala R. Limiting cardiac ischemic injury by pharmacological augmentation of macrophage migration inhibitory factor-AMP-Activated protein kinase signal transduction. Circulation 2013;128:225-236
19. Liehn EA Kanzler I Konschalla S Kroh A Simsekyilmaz S Sonmez TT Bucala R Bernhagen J Weber C. Compartmentalized protective and detrimental effects of endogenous macrophage migration-inhibitory factor mediated by CXCR2 in a mouse model of myocardial ischemia/reperfusion. Arterioscler Thromb Vasc Biol 2013;33: 2180-2186
20. Pan JH Sukhova GK Yang JT Wang B Xie T Fu H Zhang Y Satoskar AR David JR Metz CN Bucala R Fang K Simon DI Chapman HA Libby P Shi GP. Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 2004;109:3149-3153
21. Lue H Dewor M Leng L Bucala R Bernhagen J. Activation of the JNK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence onCXCR4 and CD74. Cell Signal 2011;23:135-144
22. Shi X Leng LWang TWangW Du X Li J McDonald C Chen Z Murphy JW Lolis E Noble P KnudsonW Bucala R. CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 2006;25:595-606
23. Tillmann S Bernhagen J Noels H. Arrest functions of the MIF ligand/receptor axes in atherogenesis. Front Immunol 2013;4:115
24. Zernecke A Schober A Bot I von Hundelshausen P Liehn EA Mopps B Mericskay M Gierschik P Biessen EAWeber C. SDF-1alpha/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circ Res 2005;96: 784-791
25. Hendgen-Cotta UB Kelm M Rassaf T. A highlight of myoglobin Diversity: The nitrite reductase activity during myocardial ischemia-reperfusion. Nitric Oxide 2010;22:75-82
26. Hendgen-Cotta UB Merx MW Shiva S Schmitz J Becher S Klare JP Steinhoff HJ Goedecke A Schrader J Gladwin MT Kelm M Rassaf T. Nitrite reductase activity of myoglobin regulates respiration and cellular viability in myocardial ischemia-reperfusion injury. Proc Natl Acad Sci USA 2008;105:10256-10261
27. SelkerHP Beshansky JR Sheehan PR Massaro JM Griffith JL DAgostino RB Ruthazer R Atkins JM Sayah AJ Levy MK Richards ME Aufderheide TP Braude DA Pirrallo RG Doyle DD Frascone RJ Kosiak DJ Leaming JM Van Gelder CM Walter GP WayneMAWoolard RH Opie LH Rackley CE Apstein CS Udelson JE. Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: The IMMEDIATE randomized controlled trial. JAMA 2012;307: 1925-1933
28. Benigni F Atsumi T Calandra T Metz C Echtenacher B Peng T Bucala R. The proinflammatory mediator macrophage migration inhibitory factor induces glucose catabolism in muscle. J Clin Invest 2000;106:1291-1300
29. Tong C Morrison A Yan X Zhao P Yeung EDWang J Xie J Li J. Macrophage migration inhibitory factor deficiency augments cardiac dysfunction in Type 1 diabetic murine cardiomyocytes. J Diabetes 2010;2:267-274
30. Young LH Li J Baron SJ Russell RR. AMP-Activated protein kinase: A key stress signaling pathway in the heart. Trends Cardiovasc Med 2005;15:110-118
31. Jorgensen WL Gandavadi S Du X Hare AA Trofimov A Leng L Bucala R. Receptor agonists of macrophage migration inhibitory factor. Bioorg Med Chem Lett 2010;20: 7033-7036
32. Muller II Muller KA Schonleber H Karathanos A Schneider M Jorbenadze R Bigalke B GawazM Geisler T. Macrophage migration inhibitory factor is enhanced in acute coronary syndromes and is associated with the inflammatory response. PLoS ONE 2012;7: E38376
33. Wang JC Bennett M. Aging and atherosclerosis: Mechanisms functional consequences and potential therapeutics for cellular senescence. Circ Res 2012;111:245-259
34. Koga K Kenessey A Ojamaa K. Macrophage migration inhibitory factor antagonizes pressure overload-induced cardiac hypertrophy. Am J Physiol Heart Circ Physiol 2013; 304:H282-H293
35. Boekholdt SM Peters RJ Day NE Luben R Bingham SA Wareham NJ Hack CE Reitsma PH KhawKT. Macrophage migration inhibitory factor and the risk of myocardial infarction or death due to coronary artery disease in adults without prior myocardial infarction or stroke: The EPIC-Norfolk Prospective Population study. Am J Med 2004;117: 390-397
36. Schwartz V Kruttgen A Weis J Weber C Ostendorf T Lue H Bernhagen J. Role for CD74 and CXCR4 in clathrin-dependent endocytosis of the cytokine MIF. Eur J Cell Biol 2012;91:435-449
37. Murphy JE Padilla BE Hasdemir B Cottrell GS Bunnett NW. Endosomes: A legitimate platform for the signaling train. Proc Natl Acad Sci USA 2009;106:17615-17622
38. Kleemann R Hausser A Geiger G Mischke R Burger-Kentischer A Flieger O Johannes FJ Roger T Calandra T Kapurniotu A Grell M Finkelmeier D Brunner H Bernhagen J. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 2000;408:211-216
39. Lue H Thiele M Franz J Dahl E Speckgens S Leng L Fingerle-Rowson G Bucala R Luscher B Bernhagen J. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity. Oncogene 2007;26:5046-5059
40. Kleemann R Kapurniotu A Frank RW Gessner A Mischke R Flieger O Juttner S BrunnerH Bernhagen J. Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-protein oxidoreductase. J Mol Biol 1998;280:85-102
41. Riad A Jager S Sobirey M Escher F Yaulema-Riss A Westermann D Karatas A Heimesaat MM Bereswill S Dragun D Pauschinger M Schultheiss HP Tschope C. Tolllike receptor-4 modulates survival by induction of left ventricular remodeling after myocardial infarction in mice. J Immunol 2008;180:6954-6961
42. Garner LB Willis MS Carlson DL DiMaio JM White MD White DJ Adams GA Horton JW Giroir BP. Macrophage migration inhibitory factor is a cardiac-derived myocardial depressant factor. Am J Physiol Heart Circ Physiol 2003;285:H2500-H2509
43. Chagnon F Metz CN Bucala R Lesur O. Endotoxin-induced myocardial dysfunction: Effects of macrophage migration inhibitory factor neutralization. Circ Res 2005;96: 1095-1102
44. Dhanantwari P Nadaraj S Kenessey A Chowdhury D Al-Abed Y Miller EJ Ojamaa K. Macrophage migration inhibitory factor induces cardiomyocyte apoptosis. Biochem Biophys Res Commun 2008;371:298-303
45. Stoppe C Grieb G Rossaint R Simons D Coburn M Gotzenich A Strussmann T Pallua N Bernhagen J Rex S. High postoperative blood levels of macrophage migration inhibitory factor are associated with less organ Dysfunction in patients after cardiac surgery. Mol Med 2012;18:843-850
46. Stoppe C Fries M Rossaint R Grieb G Coburn M Simons D Brucken D Bernhagen J Pallua N Rex S. Blood levels of macrophage migration inhibitory factor after successful resuscitation from cardiac arrest. PLoS ONE 2012;7:e33512
47. Gaskin FS Kamada K Zuidema MY Jones AW Rubin LJ Korthuis RJ. Isoform-selective 5'-AMP-Activated protein kinase-dependent preconditioning mechanisms to prevent postischemic leukocyte-endothelial cell adhesive interactions. Am J Physiol Heart Circ Physiol 2011;300:H1352-H1360
48. Gaskin FS Kamada K Yusof M Korthuis RJ. 5-AMP-Activated protein kinase activation prevents postischemic leukocyte-endothelial cell adhesive interactions. Am J Physiol Heart Circ Physiol 2007;292:H326-H332
49. Gaskin FS Kamada K Yusof M DuranteW Gross G Korthuis RJ. AICAR preconditioning prevents postischemic leukocyte rolling and adhesion: Role of K(ATP) channels and heme oxygenase. Microcirculation 2009;16:167-176
50. Zarrinpashneh E Carjaval K Beauloye C Ginion A Mateo P Pouleur AC Horman S Vaulont S Hoerter J Viollet B Hue L Vanoverschelde JL Bertrand L. Role of the alpha2-isoform of AMP-Activated protein kinase in the metabolic response of the heart to no-flow ischemia. Am J Physiol Heart Circ Physiol 2006;291:H2875-H2883
51. Paiva MA Rutter-Locher Z Goncalves LM Providencia LA Davidson SM Yellon DM Mocanu MM. Enhancing AMPK activation During ischemia protects the diabetic heart against reperfusion injury. Am J Physiol Heart Circ Physiol 2011;300:H2123-H2134
52. Shibata R Sato K Pimentel DR Takemura Y Kihara S Ohashi K Funahashi T Ouchi N Walsh K. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- And COX-2-dependent mechanisms. Nat Med 2005;11:1096-1103
53. Carvajal K Zarrinpashneh E Szarszoi O Joubert F Athea Y Mateo P Gillet B Vaulont S Viollet B Bigard X Bertrand L Ventura-Clapier R Hoerter JA. Dual cardiac contractile effects of the alpha2-AMPK deletion in low-flow ischemia and reperfusion. Am J Physiol Heart Circ Physiol 2007;292:H3136-H3147
54. Yoshimoto T Nishihira J Tada M Houkin K Abe H. Induction of macrophage migration inhibitory factor messenger ribonucleic acid in rat forebrain by reperfusion. Neurosurgery 1997;41:648-653
55. ShibataY Abe T Kuribayashi R Sekine S Seki K Yamagishi I Chanda J. Surgical treatment of isolated secundum atrial septal defect in patients more than 50 years old. Ann Thorac Surg 1996;62:1096-1099
56. Inacio AR Ruscher K Leng L Bucala R Deierborg T. Macrophage migration inhibitory factor promotes cell death and aggravates neurologic deficits after experimental stroke. J Cereb Blood Flow Metab 2011;31:1093-1106
57. Inacio AR Bucala R Deierborg T. Lack of macrophage migration inhibitory factor in mice does not affect hallmarks of the inflammatory/immune response during the first week after stroke. J Neuroinflammation 2011;8:75
58. Bruchfeld A Carrero JJ Qureshi AR Lindholm B Barany P Heimburger O Hu M Lin X Stenvinkel P Miller EJ. Elevated serum macrophage migration inhibitory factor (MIF) concentrations in chronic kidney disease (CKD) are associated with markers of oxidative stress and endothelial activation. Mol Med 2009;15:70-75
59. Kim H Lee S Kim HJ Kong MH Kim YR Kang SH Lee K Leng L Lee B Park CG Kook Y Kim B Bucala R. Elevated levels of macrophage migration inhibitory factor inwomenwith metabolic syndrome. Horm Metab Res 2011;43:642-645
60. Yu CM Lau CP Lai KW Huang XR Chen WH Lan HY. Elevation of plasma level of macrophage migration inhibitory factor in patients with acute myocardial infarction. Am J Cardiol 2001;88:774-777
61. Sobierajski J Hendgen-Cotta UB Luedike P Stock P Rammos C Meyer C Kraemer S Stoppe C Bernhagen J Kelm M Rassaf T. Assessment of macrophage migration inhibitory factor in humans: Protocol for accurate and reproducible levels. Free Radic Biol Med 2013;63:236-242
62. ChanW Duffy SJ White DA Gao XM Du XJ Ellims AH Dart AM Taylor AJ. Acute left ventricular remodeling following myocardial infarction: Coupling of regional healing with remote extracellular matrix expansion. JACC Cardiovasc Imaging 2012;5:884-893
63. ChanW White DAWang XY Bai RF Liu Y Yu HY Zhang YY Fan F Schneider HG Duffy SJ Taylor AJ Du XJ GaoW Gao XM Dart AM. Macrophage migration inhibitory factor for the early prediction of infarct size. J Am Heart Assoc 2013;2:e000226
64. Takahashi M Nishihira J Katsuki T Kobayashi E Ikeda U Shimada K. Elevation of plasma levels of macrophage migration inhibitory factor in patients with acute myocardial infarction. Am J Cardiol 2002;89:248-249